Cytomegalovirus: prophylaxis, preemption, or "wait and watch".
作者信息
Shoham Shmuel
出版信息
Liver Transpl. 2013 Jan;19(1):108. doi: 10.1002/lt.23564. Epub 2012 Dec 12.
Abstract
摘要
相似文献
1
Cytomegalovirus: prophylaxis, preemption, or "wait and watch".
Liver Transpl. 2013 Jan;19(1):108. doi: 10.1002/lt.23564. Epub 2012 Dec 12.
2
Cytomegalovirus: prophylaxis, preemption, or "wait and watch"--- a reply to Shoham.
Liver Transpl. 2013 Jan;19(1):109. doi: 10.1002/lt.23586.
3
Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
Liver Transpl. 2012 Dec;18(12):1448-55. doi: 10.1002/lt.23540.
4
Cytomegalovirus infection after liver transplantation incidence, risks, and benefits of prophylaxis.
Transplant Proc. 2010 Sep;42(7):2634-41. doi: 10.1016/j.transproceed.2010.04.025.
5
Cytomegalovirus.
Am J Transplant. 2004 Nov;4 Suppl 10:51-8. doi: 10.1111/j.1600-6135.2004.00727.x.
6
Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
Transpl Infect Dis. 2005 Jun;7(2):57-62. doi: 10.1111/j.1399-3062.2005.00093.x.
7
Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.
Transpl Infect Dis. 2018 Aug;20(4):e12905. doi: 10.1111/tid.12905. Epub 2018 May 24.
8
Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation.
Transpl Infect Dis. 2001;3 Suppl 2:35-9. doi: 10.1034/j.1399-3062.2001.00007.x.
9
Human beta-herpesvirus interactions in solid organ transplant recipients.
J Infect Dis. 2001 Jan 15;183(2):179-184. doi: 10.1086/317929. Epub 2000 Dec 15.
10
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
Lancet. 2000 Aug 19;356(9230):645-9. doi: 10.1016/S0140-6736(00)02607-6.
本文引用的文献
1
Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
Liver Transpl. 2012 Dec;18(12):1448-55. doi: 10.1002/lt.23540.
2
Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.
Ann Intern Med. 2005 Dec 20;143(12):870-80. doi: 10.7326/0003-4819-143-12-200512200-00005.
3
The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.
Clin Infect Dis. 2002 Oct 15;35(8):974-81. doi: 10.1086/342911. Epub 2002 Sep 26.
4
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.
Am J Med. 1997 Aug;103(2):106-13. doi: 10.1016/s0002-9343(97)80021-6.
Zotero 插件